Abstract:Laparoscopic surgery is the preferred option for many procedures. To properly perform laparoscopic surgery, it is essential that sudden movements and abdominal contractions in patients are prevented, as it limits the surgeon's view. There has been a growing interest in the potential beneficial effect of deep neuromuscular blockade (NMB) in laparoscopic surgery. Deep NMB improves the surgical field by preventing abdominal contractions, and it is thought to decrease postoperative pain. However, it is uncertain if deep NMB improves intraoperative safety and thereby improves clinical outcomes. To evaluate the benefits and harms of deep neuromuscular blockade versus no, shallow, or moderate neuromuscular blockade during laparoscopic intra‐ or transperitoneal procedures in adults. We used standard, extensive Cochrane search methods. The latest search date was 31 July 2023. We included randomised clinical trials (irrespective of language, blinding, or publication status) in adults undergoing laparoscopic intra‐ or transperitoneal procedures comparing deep NMB to moderate, shallow, or no NMB. We excluded trials that did not report any of the primary or secondary outcomes of our review. We used standard Cochrane methods. Our primary outcomes were 1. all‐cause mortality, 2. health‐related quality of life, and 3. proportion of participants with serious adverse events. Our secondary outcomes were 4. proportion of participants with non‐serious adverse events, 5. readmissions within three months, 6. short‐term pain scores, 7. measurements of postoperative recovery, and 8. operating time. We used GRADE to assess the certainty of evidence for each outcome. We included 42 randomised clinical trials with 3898 participants. Most trials included participants undergoing intraperitoneal oncological resection surgery. We present the Peto fixed‐effect model for most dichotomous outcomes as only sparse events were reported. Comparison 1: deep versus moderate NMB Thirty‐eight trials compared deep versus moderate NMB. Deep NMB may have no effect on mortality, but the evidence is very uncertain (Peto odds ratio (OR) 7.22, 95% confidence interval (CI) 0.45 to 115.43; 12 trials, 1390 participants; very low‐certainty evidence). Deep NMB likely results in little to no difference in health‐related quality of life up to four days postoperative (mean difference (MD) 4.53 favouring deep NMB on the Quality of Recovery‐40 score, 95% CI 0.96 to 8.09; 5 trials, 440 participants; moderate‐certainty evidence; mean difference lower than the mean clinically important difference of 10 points). The evidence is very uncertain about the effect of deep NMB on intraoperatively serious adverse events (deep NMB 38/1150 versus moderate NMB 38/1076; Peto OR 0.95, 95% CI 0.59 to 1.52; 21 trials, 2231 participants; very low‐certainty evidence), short‐term serious adverse events (up to 60 days) (deep NMB 37/912 versus moderate NMB 42/852; Peto OR 0.90, 95% CI 0.56 to 1.42; 16 trials, 1764 participants; very low‐certainty evidence), and short‐term non‐serious adverse events (Peto OR 0.94, 95% CI 0.65 to 1.35; 11 trials, 1232 participants; very low‐certainty evidence). Deep NMB likely does not alter the duration of surgery (MD −0.51 minutes, 95% CI −3.35 to 2.32; 34 trials, 3143 participants; moderate‐certainty evidence). The evidence is uncertain if deep NMB alters the length of hospital stay (MD −0.22 days, 95% CI −0.49 to 0.06; 19 trials, 2084 participants; low‐certainty evidence) or pain scores one hour after surgery (MD −0.31 points on the numeric rating scale, 95% CI −0.59 to −0.03; 22 trials, 1823 participants; very low‐certainty evidence; mean clinically important difference 1 point) and 24 hours after surgery (MD −0.60 points on the numeric rating scale, 95% CI −1.05 to −0.15; 16 trials, 1404 participants; very low‐certainty evidence; mean clinically important difference 1 point). Comparison 2: deep versus shallow NMB Three trials compared deep versus shallow NMB. The trials did not report on mortality and health‐related quality of life. The evidence is very uncertain about the effect of deep NMB compared to shallow NMB on the proportion of serious adverse events (RR 1.66, 95% CI 0.50 to 5.57; 2 trials, 158 participants; very low‐certainty evidence). Comparison 3: deep versus no NMB One trial compared deep versus no NMB. There was no mortality in this trial, and health‐related quality of life was not reported. The proportion of serious adverse events was 0/25 in the deep NMB group and 1/25 in the no NMB group. There was insufficient evidence to draw conclusions about the effects of deep NMB compared to moderate NMB on all‐cause mortality and serious adverse events. Deep NMB likely results in little to no difference in health‐related quality of life and duration of surgery compared to moderate NMB, and it may have no effect on the length of hospital stay. Due to the very low -Abstract Truncated-

Effects of depth of neuromuscular block on surgical operating conditions in women undergoing gynecologic laparoscopic surgery: a randomized clinical trial

Effects of Deep and Moderate Neuromuscular Blockade on Surgical Conditions During Minor Laparoscopic Gynecologic Surgery

Evaluation of surgical condition during laparoscopic gynaecological surgery in patients with moderate vs. deep neuromuscular block in low-pressure pneumoperitoneum

Comparison of Deep and Moderate Neuromuscular Blockade for Major Laparoscopic Surgery in Children: A Randomized Controlled Trial

MRI measurement of the effects of moderate and deep neuromuscular blockade on the abdominal working space during laparoscopic surgery, a clinical study

Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis

Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure

Does deep neuromuscular blockade provide improved perioperative outcomes in adult patients? A systematic review and meta-analysis of randomized controlled trials

Effects of depth of neuromuscular blockade on the BIS-guided propofol requirement: A randomized controlled trial

[The effect of deep neuromuscular block combined with low pneumoperitoneum pressure on postoperative pain in patients undergoing laparoscopic radical colorectal surgery]

The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial

Effect of Pneumoperitoneum Pressure and the Depth of Neuromuscular Block on Renal Function in Patients with Diabetes Undergoing Laparoscopic Pelvic Surgery: Study Protocol for a Double-Blinded 2 × 2 Factorial Randomized Controlled Trial.

Deep Neuromuscular Block Attenuates Chronic Postsurgical Pain and Enhances Long-Term Postoperative Recovery After Spinal Surgery: A Randomized Controlled Trial

Comparison of the Effects of Deep and Moderate Neuromuscular Block on Respiratory System Compliance and Surgical Space Conditions During Robot-Assisted Laparoscopic Radical Prostatectomy: a Randomized Clinical Study

Effect of deep neuromuscular block on the quality of early recovery after sleeve gastrectomy in obese patients: a randomized controlled trial

Effects of Differences in Epidural Needle Entry Point and Angle of Rotation of Needle Hub on the Onset and Duration of Sensory Blockade in Lower Limb Orthopaedic Surgeries: A Randomised Controlled Trial

Impact of low-pressure pneumoperitoneum and deep neuromuscular blockade on surgeon satisfaction and patient outcomes in laparoscopic cholecystectomy patients: A prospective randomised controlled study

The impact of biological sex in peripheral nerve blockade: A prospective pharmacodynamic, pharmacokinetic and morphometric study in volunteers

Observation on the effect of intraoperative risk management combined with comfort nursing in gynecological laparoscopic surgery

Intraoperative protective ventilation in patients undergoing major neurosurgical interventions: a randomized clinical trial

The perioperative effect of anesthetic drugs on the immune response in total intravenous anesthesia in patients undergoing minimally invasive gynecological surgery